The FDA Approved a New Drug To Treat Alzheimer’s, but Medicare Won’t Always Pay for It – A Doctor Explains Biogen’s Aduhelm
On April 8, 2022, Medicare finalized its decision to restrict its coverage of Aduhelm, Biogen’s new Alzheimer’s disease treatment. The decision means that only patients…